Applications published 21 February 2007
Enteric solid oral dosage form of a bisphophonate containing a chelating agent
Procter & Gamble 1753395*
Composite material for use as a protein carrier
Scii Technology 1753396*
Galantamine salts, methods of producing it and nasal compsns thereof
Nastech Pharmaceutical 1753397*
Controlled release matrix pharmaceutical dosage formulation
Glatt Air Techniques 1753398*
Ziprasidone dosage form
Dr Reddy's Laboratories 1753400*
Rapidly soluble granulate of bromohexine or bromohexine hydrochloride, method for the production of said granulate and the use thereof
Boehringer Ingelheim Vetmedica 1753401*
Pharmaceutical compsns with enhanced performance
Pfizer Products 1753402*
Particulate comprising a calcium containing compound and a sugar alcohol
Nycomed Danmark 1753403*
Microspheres comprising protein and showing injectability at high concentrations of said agent
Baxter International 1753404*
Controlled release pharmaceutical formulation
Glatt Air Techniques 1753405*
Coated tablet formulation and method
Bristol-Myers Squibb 1753406*
Sugar coatings and methods therefor
Wyeth 1753407*
Hormonal contraceptive containing a combination of ethinyl estradiol and chlormadinone acetate
Gruenenthal 1753408*
Dosage form containing the active ingredient cholylsarcosine
Roehm 1753409*
Multilayered controlled-release methylphenidate pellet
Laboratoires Rubio 1753410*
Methods of manufacture and use containing phosphate particles containing allergens
Biosante Pharmaceuticals 1753411*
Self-adhesive pharmaceutical patch
Reckitt-Benckiser Healthcare (UK) 1752412*
Novel medical uses of compounds showing CB SB 1/SB antagonistic activity and combination treatment involving said compounds
Solvay Pharmaceuticals 1753413*
Novel use of peptide compounds for treating dyskinesia
Schwartz Pharma 1753414*
Novel use of peptide compounds for treating pain in trigeminal neuralgia
Schwarz Pharma 1753415*
Anti-retroviral moronic acid derivatives
The University of North Carolina at Chapel Hill 1753416*
Selective androgen receptor modulators and methods of use thereof
University of Tennessee Research Foundation 1753417*
Compsns comprising nebivolol
Mylan Laboratories 1753418*
Anticancer and antiprotozoal dihydroartemisinene and dihydroartemisinene dimers with desirable chemical functionalities
University of Mississippi 1753419*
Indole derivatives useful for treating resistance to antitumour agents
Nikem Research; Istituto Nazionale per lo Studio e la Cura dei Tumori 1753420*
Small molecule inhibitors for MRP1 and other multidrug transporters
The Cleveland Clinic Foundation; The University of New South Wales 1753422*
Benzoureas having anti-diabetic activity
Merck 1753423*
A therapeutic agent containing nicotinic acid or its derivatives as an effective ingredient for prevention and treatment of cancer
Biorunx 1753425*
Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
Janssen Pharmaceutica 1753427*
Kinase inhibitors as therapeutic agents
Abbott Laboratories 1753428*
Modulators of muscarinic receptors
Vertex Pharmaceuticals 1753429*
Combination of atomexetine and a 5HT1A receptor agonist for treating ADHD and other disorders
Warner-Lambert 1753430*
Pharmaceutical compsns comprising ZD6474
AstraZeneca 1753431*
Medicaments containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction
Solvay Pharmaceuticals 1753432*
Pharmaceutical compsns comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and PDE V inhibitors
Solvay Pharmaceuticals 1753433*
Enhanced bimatoprost ophthalmic solution
Allergan 1753434*
Use of a combination of ethinyl estradiol and chlormadinobene acetate for the production of a medicament
Gruenenthal 1753435*
Anhydrous pharmaceutical compsn associating a siliconated agent and solubilised active principle
Galderma Research & Development 1753436*
Bicarbonate-based peritoneal dialysis solutions
Baxter International 1753437*
New hydroxyapatite calcium phosphates, their method of preparation and their applications
Innophos 1753438*
Use of umbilical cord blood stem cells to treat ischaemic event
Regents of the University of Minnesota 1753439*
Oral form of administration containing probiotic bacteria
Merck Patent 1753440*
Polypeptides for inducing a protective immune response against Staphylococcus aureus
Merck 1753441*
Method of administering and using VEGF inhibitors for the treatment of human cancer
Regeneron Pharmaceuticals 1753442*
Use of protein hydrolysates for the manufacture of a medicament for prophylaxis and/or treatment of a DPP-IV mediated condition
Campina Nederland Holding 1753443*
Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical compsn therefor in form of a kit
Ammannati, Paola; Giordani, Roberto 1753444*
Treatment of ocular diseases and disorders using lantibiotic compsns
Molichem Medicines 1753445*
Alpha-1-acid glycoprotein for the treatment of diabetes
Essential Skincare 1753446*
Immune response suppressor and treatment of multiple sclerosis
Research Development Foundation 1753447*
Compsns comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof
Genencor International; Dow Corning 1753448*
Methods and compsns for control of fetal growth via modulation of relaxin
BAS Medical 1753449*
Process for the isolation and/or purification of proteins
LEK Pharmaceuticals 1753450*
Local delivery of growth factors for stem cell transplantation
Conor Medsystems 1753451*
A method for altering the CD4/CD8 ratio and the mononuclear cellular infiltrate into a tumour
Cel-Sci Corporation 1753452*
Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist
Coley Pharmaceutical 1753453*
Vaccine for periodontal disease
Pfizer Products 1753454*
Method for treating multiple sclerosis
Genentech 1753455*
Methods for treating conditions associated with MASP-2 dependent complement activation
Omeros Corp; University of Leicester 1753456*
Cationic bacteriochlorophyl derivatives and uses thereof
Yeda Research and Development 1753457*
Modulation of immunoglobulin production and atopic disorders
Wyeth 1753458*
Compsn and method for improving pancreatic islet cell survival
Yasoo Health 1753459*
Combination of atypical antipsychotics and 5-HT1B receptor antagonists
Pfizer Products 1753460*
Stabilised compsns comprising a therapeutically active agent, citric acid of a conjugated base and chlorine dioxide
Allergan 1753461*
Process for the preparation of doxorubicin conjugates with lactosaminated human albumin and the obtained conjugates
Universitàdi Bologna 1753462*
Antibody drug conjugates and methods
Genentech 1753463*
Annexin II and uses thereof
Quark Biotech; Astellas Pharma 1753464*
Assay for transmissible spongiform encephalopathies
The Administrators of the Tulane Educational Fund 1753465*
Copolymers comprising positively and negatively charged aminoacids conjugated to chelants
General Electric 1753466*
Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes and methods for positron emission imaging with radiolabelled halogenated xanthene diagnostic agents
Xantech Pharmaceuticals 1753467*
Carboranylporphyrins and uses thereof
Brookhaven Science Associates 1753468*